Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-03 Purchase | 2023-01-05 5:08 pm | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 110,000 | $1.4165 | $155,815 | 174,000 (Direct) | View |
| 2020-04-07 Purchase | 2020-04-13 4:05 pm | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 64,000 | $2.426 | $155,264 | 64,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-29 Option Award | 2023-10-03 5:00 pm | N/A 2033-09-29 | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 61,676 | $0 | 61,676 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:02 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:40 pm | N/A 2025-06-22 | Foamix Pharmaceuticals Ltd. | FOMX | Schwartz Aharon Director | 270,086 | $0 | 0 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 4:33 pm | N/A 2030-02-27 | Foamix Pharmaceuticals Ltd. | FOMX | Schwartz Aharon Director | 38,156 | $0 | 38,156 (Direct) | View |
| 2020-01-20 Option Award | 2020-01-22 5:02 pm | N/A 2030-01-20 | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 6:36 pm | N/A 2029-05-16 | Foamix Pharmaceuticals Ltd. | FOMX | Schwartz Aharon Director | 49,412 | $0 | 49,412 (Direct) | View |